Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH])

Am J Cardiol. 2002 Jul 15;90(2):181-4. doi: 10.1016/s0002-9149(02)02449-9.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticholesteremic Agents / administration & dosage*
  • Anticholesteremic Agents / adverse effects
  • Apolipoproteins / blood
  • Apolipoproteins / drug effects
  • Creatine Kinase / drug effects
  • Female
  • Follow-Up Studies
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / drug therapy*
  • Lipoproteins / blood
  • Lipoproteins / drug effects
  • Liver Function Tests
  • Male
  • Middle Aged
  • Muscular Diseases / chemically induced
  • Simvastatin / administration & dosage*
  • Simvastatin / adverse effects
  • Time Factors
  • Transaminases / drug effects
  • Treatment Outcome
  • Triglycerides / blood

Substances

  • Anticholesteremic Agents
  • Apolipoproteins
  • Lipoproteins
  • Triglycerides
  • Simvastatin
  • Transaminases
  • Creatine Kinase